Rein Therapeutics Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BIOS CAPITAL MANAGEMENT, LP | 05/14/2025 | 1.69 M | $2.99 M | 0.00% | 7,793.99% |
VOSS CAPITAL, LLC | 05/14/2025 | 990.72 K | $1.75 M | 3.61% | 4,566.98% |
VANGUARD GROUP INC | 05/09/2025 | 716.79 K | $1.27 M | 68.66% | 3,304.24% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | 05/07/2025 | 511.61 K | $905.55 K | -17.10% | 2,358.41% |
PROSIGHT MANAGEMENT, LP | 05/15/2025 | 430.00 K | $761.10 K | 6.18% | 1,982.21% |
CABLE CAR CAPITAL LLC | 05/15/2025 | 420.00 K | $743.40 M | 0.00% | 1,936.11% |
SIGMA PLANNING CORP | 05/02/2025 | 305.18 K | $540.16 K | 29.20% | 1,406.79% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 246.10 K | $435.72 K | 1.93% | 1,134.45% |
SENVEST MANAGEMENT, LLC | 05/14/2025 | 230.90 K | $408.68 K | 0.00% | 1,064.38% |
GAGNON SECURITIES LLC | 05/09/2025 | 71.75 K | $126.99 K | 0.00% | 330.73% |
ROYAL BANK OF CANADA | 05/15/2025 | 57.26 K | $101.00 K | -46.47% | 263.94% |
BLACKROCK, INC. | 05/02/2025 | 51.30 K | $90.81 K | -35.02% | 236.50% |
CHICAGO PARTNERS INVESTMENT GROUP LLC | 05/09/2025 | 35.91 K | $58.54 K | 100.00% | 165.55% |
EXENCIAL WEALTH ADVISORS, LLC | 05/09/2025 | 30.53 K | $54.04 K | 0.00% | 140.73% |
MERIDIAN WEALTH ADVISORS, LLC | 05/05/2025 | 28.49 K | $50.42 K | 100.00% | 131.31% |
TEXAS CAPITAL BANK WEALTH MANAGEMENT SERVICES INC | 05/14/2025 | 26.17 K | $46.32 K | 0.00% | 120.64% |
NORTHERN TRUST CORP | 05/13/2025 | 25.76 K | $45.60 K | 0.00% | 118.76% |
BLAIR WILLIAM & CO/IL | 05/09/2025 | 23.62 K | $41.81 K | -7.73% | 108.89% |
KCK LTD. | 07/11/2025 | 22.34 K | $39.54 K | 0.00% | 102.99% |
KG&L CAPITAL MANAGEMENT,LLC | 04/23/2025 | 18.00 K | $31.86 K | 0.00% | 82.98% |
TWO SIGMA SECURITIES, LLC | 05/15/2025 | 16.27 K | $28.80 K | 100.00% | 75.01% |
STATE STREET CORP | 05/15/2025 | 16.00 K | $28.33 K | 0.00% | 73.78% |
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 05/14/2025 | 15.44 K | $27.33 K | 100.00% | 71.18% |
NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 05/15/2025 | 11.19 K | $19.81 K | 100.00% | 51.60% |
AMERICANA PARTNERS, LLC | 05/12/2025 | 11.10 K | $19.65 K | 100.00% | 51.18% |
MORGAN STANLEY | 05/15/2025 | 4.30 K | $7.61 K | 0.00% | 19.82% |
TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 3.46 K | $6.12 K | 33.99% | 15.94% |
UBS GROUP AG | 05/13/2025 | 2.98 K | $5.28 K | -58.90% | 13.74% |
JFS WEALTH ADVISORS, LLC | 04/22/2025 | 1.59 K | $2.82 K | 0.00% | 7.33% |
US BANCORP \DE\ | 05/08/2025 | 1.25 K | $2.21 K | 0.00% | 5.76% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 241 | $427 | -15.14% | 1.11% |
HEXAGON CAPITAL PARTNERS LLC | 04/29/2025 | 213 | $377 | 0.00% | 0.98% |
ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 140 | $248 | 100.00% | 0.65% |
JPMORGAN CHASE & CO | 05/12/2025 | 32 | $57 | 6.67% | 0.15% |
GAME PLAN FINANCIAL ADVISORS, LLC | 05/19/2025 | 25 | $44 | 0.00% | 0.12% |
RONALD BLUE TRUST, INC. | 04/21/2025 | 20 | $35 | 100.00% | 0.09% |
WELLS FARGO & COMPANY/MN | 05/13/2025 | 2 | $4 | 100.00% | 0.01% |
Rein Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 35 institutional investors and hedge funds held shares of Rein Therapeutics Inc.. The most heavily invested institutionals were:
BIOS Capital Management, LP: 1.69 M
Voss Capital, LLC: 990,716
VANGUARD GROUP INC: 716,788
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO: 511,610
Prosight Management, LP: 430,000
Cable Car Capital LLC: 420,000
27,739.00% of Rein Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 5.98 M shares in the last 24 months. This purchase volume represents approximately $8.43 M in transactions.